Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of MK-0431/ONO-5435 in
patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise
therapy and glimepiride as monotherapy